Ampullary Gangliocytic paraganglioma is a rare gastro-entero-pancreatic neuroendocrine tumor with a characteristic histologic appearance involving epitheliod, spindle and ganglion cells. Endoscopic ultrasound is useful to determine depth of invasion and regional metastasis. Endoscopic resection, Ampullectomy and pancreato-duodenenectomy have been described as management options in literature but no consensus has been established. The index case describes an asymptomatic 42 y/o lady with a background of plexiform neurofibromatosis referred for cholestatic derangement of liver function. She was found to have a dilated biliary system with a periampullary mass which proved to be a Gangliocytic Paraganglioma without local lymph node metastasis. She underwent successful endoscopic ampullectomy with complete normalization of LFT and decompression of the biliary system with no clinical or endoscopic recurrence at 2 years follow up. We advocate that Partial Ampullectomy could be done safely as a treatment of localized Ampullary GP allowing long term resolution of symptoms.
Introduction
A mpullary gangliocytic paraganglioma (AGP) is a rare gastro-entero-pancreatic neuroendocrine tumor with a characteristic histologic appearance involving epithelioid, spindle, and ganglion cells. They are generally detected incidentally or when they present with upper gastrointestinal (GI) bleed. Most of these tumors are detected either on a contrast computed tomography or magnetic resonance imaging (MRI) . Although this tumor is mostly considered benign, most of the patients undergo pancreatoduodenectomy (Whipple's operation).
Case Report
An asymptomatic 42-year-old female was referred for evaluation of abnormal liver functions tests. History included plexiform neurofibroma of foot and thigh at the of age 19 years, laparoscopic cholecystectomy at the age of 34 years and tonic-clonic seizures secondary to parieto-occipital gliosis at the age of 37 years. She was on treatment with levetiracetam as seizure prophylaxis.
with a 14 mm hypoechoic submucosal lesion at the ampulla without any local lymph nodes [ Figure 1a ]. Biopsy from the ampullary specimen revealed nests of epithelial cells without significant pleomorphism with occasional ganglion-like cells with large and oval nucleus [ Figure 1d ]. Immunohistochemistry revealed epithelial cells stained positive for cytokeratin (CK) 7, synaptophysin, and chromogranin and were negative for S-100 and nonspecific enolase (NSE). The ganglion cells stained positive for S-100, synaptophysin, chromogranin, and NSE and were negative for CK. A diagnosis of AGP was made.
The patient underwent ampullectomy with biliary sphincteroplasty with 5 Fr prophylactic stent into the PD [ Figure 1b ]. The resected specimen confirmed the previous diagnosis of AGP, a benign lesion without malignant potential. There were no signs of cellular atypia or mitotic figures.
On the last follow-up at 2-year postsurgery, the patient was doing well with complete normalization of liver function tests with repeat biopsies from the ampulla being negative for dysplasia or malignancy.
Discussion
AGP is a rare gastro-entero-pancreatic neuroendocrine tumor with a characteristic histologic appearance involving epithelioid, spindle, and ganglion cells. [1] Paragangliomas of GI tract have been described in association with neurofibromatosis Type 1 or Von Recklinghausen's Disease. [2, 3] The patient in the index case had a background of plexiform neurofibromatosis, a form of neurofibromatosis Type 1 diagnosed at a young age. Burke and Helwig described a review of 51 patients with gangliocytic paragangliomas of GI tract with 49 of them occurring in the duodenum. [4] Although patients may present with abdominal pain or GI bleeding due to mucosal or submucosal invasion, patients may often remain asymptomatic; [5] as in our patient. Histological diagnosis is based on the presence of admixture of epithelioid, ganglion, and spindle-shaped cells. Immunohistochemical staining shows positive reaction for neuron-specific enolase, chromogranin A, and S-100 protein. [4] The first step in the management of ampullary lesions is to determine the depth of invasion using an EUS and cross-sectional imaging. EUS findings were first described by Smithline et al. in 1993. [5] AGPs have been described as isoechoic or hypoechoic, round well-demarcated submucosal tumors arising from the third or fourth layer [6] of duodenal wall. EUS not only detects these lesions with ease due to its anatomical position but also rules out its deeper penetration or involvement of regional lymph nodes. Regarding its treatment, endoscopic resection is the treatment of choice when the tumor is localized. [7] Long-term outcomes from such an approach have proven to be favorable with no recurrence or metastasis. [8] More recently, endoscopic mucosal resection (EMR) has been described for resection of such tumors. [9, 10] Endoscopic ampullectomy offers a minimally invasive approach for treating peri-ampullary lesions. [11] Both EMR and ampullectomy are feasible options when lesion is limited to the ampulla and has no evidence of regional lymphatic spread. A surgical ampullectomy has also been described when tumor involves the CBD. [12] Endoscopic ampullectomy as a mode of tumor excision was chosen in the index case with dilated CBD and PD, after determining that there is no deeper invasion and there is a lack of lymph nodal involvement. A prophylactic pancreatic stent was placed to reduce the risk of postampullectomy pancreatitis. [13] Patient follow-up at 3 years has shown no tumor recurrence or metastatic disease. We recommend that a minimal risk endoscopic approach over a comparatively invasive surgical approach when choosing ampullectomy. Finally, more invasive procedures such as pancreatoduodenectomy may be reserved for cases with local or lymphovascular invasion. 
Conclusion
The index case highlights the association of Neurofibromatosis with AGP and the role of EUS in the management of this condition. Based on the current report, we suggest that endoscopic ampullectomy could be done safely allowing long-term resolution of symptoms in cases of AGP without local metastasis.
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